Orelabrutinib in Combination With R2 Regimen for R/R CD20+ B-cell Lymphoma
Clinical trial NCT05014100 · UNKNOWN
Trial details
- NCT number
- NCT05014100
- Sponsor
- Puyang Oilfield General Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-01
- Primary completion
- 2022-09-30
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.